Restenosis prevention after percutaneous transluminal coronary angioplasty with N-3 fatty acids: Results of the randomized, double-blind, placebo controlled ''ESPRIT'' study.

被引：0
|
作者：
Maresta, A
机构：
来源：
CIRCULATION | 1996年 / 94卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3630 / 3630
页数：1
相关论文
共 50 条
  • [41] N-3 polyunsaturated fatty acids: Prophylaxis and symptomatic therapy for oxaliplatin-induced peripheral neuropathy-A randomized, double-blind placebo controlled trial.
    Ghoreishi, Zohreh
    Somi, Mohammad Hossein
    Ayromlou, Hormoz
    Jafarabadi, Mohammad Asghari
    Esfahani, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] BUCCAL NITROGLYCERIN DECREASES ISCHEMIC PAIN DURING CORONARY ANGIOPLASTY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    JOHANSSON, SR
    EKSTROM, L
    EMANUELSSON, H
    AMERICAN HEART JOURNAL, 1990, 120 (02) : 275 - 281
  • [43] PLACEBO-CONTROLLED, DOUBLE-BLIND CROSSOVER STUDY WITH SUBSTITUTION OF N-3 FATTY-ACIDS IN PATIENTS WITH CROHNS-DISEASE AND ULCERATIVE-COLITIS
    LOESCHKE, K
    LORENZ, R
    SZIMNAU, P
    HELDWEIN, W
    STRASSER, T
    WEBER, PC
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (09): : 473 - 473
  • [44] Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403
  • [45] Effect of omeprazole in functional dyspepsia: A double-blind, randomized, placebo-controlled study.
    Lauritsen, K
    Aalykke, C
    Havelund, T
    Knudsen, T
    Glise, H
    Unge, P
    Ekstrom, P
    Jaup, B
    Norrby, A
    Stubberod, A
    Melen, K
    Bolling, E
    Jerndal, P
    Junghard, O
    GASTROENTEROLOGY, 1996, 110 (04) : A702 - A702
  • [46] Bromocriptine in systemic lupus erythematosus: A double-blind, randomized placebo-controlled study.
    AlvarezNemegyei, J
    CovarrubiasCobos, A
    EscalanteTriay, F
    SosaMunoz, G
    Jara, LJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1351 - 1351
  • [47] Evaluation of the effect of oral verapamil on clinical outcome and angiographic -: Restenosis after percutaneous coronary intervention -: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial
    Bestehorn, HP
    Neumann, FJ
    Büttner, HJ
    Betz, P
    Stürzenhofecker, P
    von Hodenberg, E
    Verdun, A
    Levai, L
    Monassier, JP
    Roskamm, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 2160 - 2165
  • [48] RESULTS OF A RANDOMIZED TRIAL OF TICLOPIDINE VERSUS PLACEBO FOR PREVENTION OF ACUTE CLOSURE AND RESTENOSIS AFTER CORONARY ANGIOPLASTY (PTCA) THE TACT STUDY
    BERTRAND, ME
    ALLAIN, H
    LABLANCHE, JM
    CIRCULATION, 1990, 82 (04) : 190 - 190
  • [49] A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib
    Hausleiter, J
    Zohlnhöfer, D
    Mehilli, J
    Goos, C
    Schühlen, H
    Pache, J
    Pogatsa-Murray, G
    Dirschinger, J
    Kastrati, A
    CIRCULATION, 2005, 112 (17) : U714 - U715
  • [50] Randomized, double-blind, placebo-controlled trial of oral rapamycin for prevention of recurrent in-stent-restenosis
    Mehilli, J
    Hausleiter, J
    Goos, C
    Breuer, M
    Bollwein, H
    Dibra, A
    Kastrati, A
    Schömig, A
    EUROPEAN HEART JOURNAL, 2004, 25 : 241 - 241
12345